Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Gilead Sciences, Inc. company logo
Gilead Sciences, Inc. logo

Gilead Sciences, Inc. (GILD)

Profile

Company profile for Gilead Sciences, Inc. (GILD)
MetricValue
Full NameGilead Sciences, Inc.
TickerNASDAQ: GILD
ExchangeNASDAQ
SectorHealthcare
IndustryGeneral Drug Manufacturers
CountryUnited States
IPO
Indexes
Websitegilead.com
Employees17,600

Key Metrics

Gilead Sciences, Inc. Key Details
MetricDateValue
Price$121.76
Price, 1D Change-0.69%
Market Cap$151B
TTM Dividend Yield2.60%
PE Ratio18.86
Beta0.35
Revenue$29B
Revenue, 1Y Change+6.17%
EPS$0.38
EPS, 1Y Change-91.51%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
Gilead Sciences, Inc. chart

Events

Gilead Sciences, Inc. Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-Dividend$0.79
Next Ex-DividendN/AN/A
Last Split2:1
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

GILD Estimates
MetricDateValue
EPS$0.38
EPS Estimate$8.16
EPS Est. Change+2,032.65%
Revenue$28.73B
Revenue Estimate$29.21B
Revenue Est. Change+1.69%
Current Price$121.76
Price Target-$135.00
Price Tgt. Change-+10.87%

🔒 Log In To Unlock Full Data

EPS

GILD EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
$6.76$4.50-33.38%
$4.41$0.38-91.32%
$8.16N/A+2,032.65%
$8.77N/A+2,193.25%
GILD EPS reported versus estimate values chart

Revenue

GILD revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$27.10B$27.06B-0.14%
$28.30B$28.73B+1.49%
$29.21BN/A+1.69%
$30.18BN/A+5.05%
GILD revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

GILD Performance
MetricDateValue
Price, 1Y+35.38%
Price, 3Y+41.14%
Market Cap, 1Y+34.77%
Market Cap, 3Y+40.42%
Revenue, 1Y+6.17%
Revenue, 3Y+4.95%
EPS, 1Y-91.51%
EPS, 3Y-92.25%

🔒 Log In To Unlock Full Data

Technical Indicators

GILD Technical Indicators
MetricDateValue
Current Price$121.76
SMA 200$114.23
SMA 200 vs Price-6.18%
SMA 50$123.03
SMA 50 vs Price+1.04%
Beta0.35
ATR$3.13
14-Day RSI48.49
10-Day Volatility30.55%
1-Year Volatility28.33%

Dividends

GILD Dividends
MetricDateValue
Last Paid$0.79
UpcomingN/AN/A
Dividend Yield2.53%
Total Dividend$3.08
Dividends Paid$3.92B
Payout Ratio816.25%

🔒 Log In To Unlock Full Data

Income & Profitability

GILD Income & Profitability
MetricDateValue
Revenue$28.73B
EPS$0.38
Gross Profit$22.50B
Gross Margin78.24%
Operating Profit$10.51B
Operating Margin36.53%
Net Income$480.00M
Net Margin1.67%
EBITDA$1.67B

🔒 Log In To Unlock Full Data

Financial Health

GILD Financial Health
MetricDateValue
Debt To Equity0.00
Current Ratio1.50
Quick Ratio1.36
-
F-Score8
Altman Z-Score3.26

Valuations

GILD Valuations
MetricDateValue
PE Ratio18.86
PS Ratio5.20
PB Ratio7.01
EV/EBITDA11.83
Enterprise ValueN/A-

Balance Sheet

GILD Balance Sheet
MetricDateValue
Book Value$19.25B
Cash & Equivalents$9.99B
Total Assets$59.00B
Current Assets$18.00B
Total Liabilities$39.75B
Current Liabilities$12.00B
Total Debt$27.32B
Short Term Debt$1.93B
Accounts Payable$833.00M

Expenses

GILD Expenses
MetricDateValue
Total Expenses$18.25B
Operating Expenses$12.00B
Cost Of Goods Sold$6.25B
SG&A$6.09B
D&A$2.77B
Interest Expense$0.00
Income Tax$210.00M

Cash Flow

GILD Cash Flow
MetricDateValue
CFO$10.83B
CFI-$3.45B
CFF-$3.43B
Capex$523.00M
Free Cash Flow$10.83B

Recent analyst updates

GILD Recent analyst updates
MetricDateValue
Citigroup→
Morgan Stanley→
Wells Fargo→
Scotiabank
Needham→
Truist Securities→
Wells Fargo→
RBC Capital→
Needham→
JP Morgan→

Analyst sentiment

Sentiment over the past month
GILD analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
GILD institutional ownership distribution chart

Screeners with GILD

Data Sources & References

  1. GILD Official Website www.gilead.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/882095/000088209525000044/0000882095-25-000044-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/882095/000088209525000006/0000882095-25-000006-index.htm
  4. List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
  5. List of NASDAQ 100 Companies www.nasdaq.com/market-activity/quotes/nasdaq-ndx-index
  6. GILD Profile on Yahoo Finance finance.yahoo.com/quote/GILD
  7. GILD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gild

FAQ

  • What is the ticker symbol for Gilead Sciences, Inc.?

    The ticker symbol for Gilead Sciences, Inc. is NASDAQ:GILD

  • Does Gilead Sciences, Inc. pay dividends?

    Yes, Gilead Sciences, Inc. pays dividends. The last payment was $0.79, with an ex-dividend date on December 15, 2025

  • What sector is Gilead Sciences, Inc. in?

    Gilead Sciences, Inc. is in the Healthcare sector

  • What industry is Gilead Sciences, Inc. in?

    Gilead Sciences, Inc. is in the General Drug Manufacturers industry

  • What country is Gilead Sciences, Inc. based in?

    Gilead Sciences, Inc. is headquartered in United States

  • When did Gilead Sciences, Inc. go public?

    Gilead Sciences, Inc. initial public offering (IPO) was on January 22, 1992

  • Is Gilead Sciences, Inc. in the S&P 500?

    Yes, Gilead Sciences, Inc. is included in the S&P 500 index

  • Is Gilead Sciences, Inc. in the NASDAQ 100?

    Yes, Gilead Sciences, Inc. is included in the NASDAQ 100 index

  • Is Gilead Sciences, Inc. in the Dow Jones?

    No, Gilead Sciences, Inc. is not included in the Dow Jones index

  • When was Gilead Sciences, Inc. last earnings report?

    Gilead Sciences, Inc.'s most recent earnings report was on October 30, 2025

  • When does Gilead Sciences, Inc. report earnings?

    The next expected earnings date for Gilead Sciences, Inc. is February 10, 2026